Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 509

1.

B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.

Price JF, Thomas AK, Grenier M, Eidem BW, O'Brian Smith E, Denfield SW, Towbin JA, Dreyer WJ.

Circulation. 2006 Sep 5;114(10):1063-9. Epub 2006 Aug 28.

2.

Relationship of brain natriuretic peptide concentrations to left ventricular function and adverse outcomes in children with end-stage renal disease undergoing hemodialysis.

Ouali S, Bougmiza I, Abroug S, Omezzine A, Ben Salem H, Neffeti E, Remedi F, Bouslema A, Harabi A, Boughzela E.

Pediatr Cardiol. 2011 Jun;32(5):568-77. doi: 10.1007/s00246-011-9909-8. Epub 2011 Feb 20.

PMID:
21336977
3.

B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.

Post F, Weilemann LS, Messow CM, Sinning C, Münzel T.

Crit Care Med. 2008 Nov;36(11):3030-7. doi: 10.1097/CCM.0b013e31818b9153.

PMID:
18824903
4.

Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.

Law YM, Ettedgui J, Beerman L, Maisel A, Tofovic S.

Am J Cardiol. 2006 Aug 15;98(4):520-4. Epub 2006 Jun 27.

PMID:
16893709
5.
6.

B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy.

Kaski JP, Tomé-Esteban MT, Mead-Regan S, Pantazis A, Marek J, Deanfield JE, McKenna WJ, Elliott PM.

Heart. 2008 Oct;94(10):1307-11. Epub 2007 Dec 10.

PMID:
18070943
7.
8.

[Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].

Pascual-Figal DA, Peñafiel P, Nicolas F, de la Morena G, Ansaldo P, Redondo B, Sánchez Mas J, Valdés M.

Rev Esp Cardiol. 2008 Mar;61(3):260-8. Spanish.

9.

Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.

Isnard R, Pousset F, Chafirovskaïa O, Carayon A, Hulot JS, Thomas D, Komajda M.

Am Heart J. 2003 Oct;146(4):729-35.

PMID:
14564330
10.

B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.

Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Bickel C, Lackner KJ, Cambien F, Tiret L, Münzel T, Blankenberg S.

J Am Coll Cardiol. 2006 Feb 7;47(3):552-8. Epub 2006 Jan 18.

11.

Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.

Passino C, Maria Sironi A, Favilli B, Poletti R, Prontera C, Ripoli A, Lombardi M, Emdin M.

Int J Cardiol. 2005 Sep 15;104(1):39-45.

PMID:
16137508
12.

Increase of B-type natriuretic peptide from baseline increases the risk of death or retransplant in pediatric cardiac transplant patients, midterm results.

Bramlet M, Moore R, Murphy D, Caldwell R, Darragh R, Schamberger M.

Congenit Heart Dis. 2010 May-Jun;5(3):297-302. doi: 10.1111/j.1747-0803.2010.00417.x.

PMID:
20576050
13.

Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.

Rogers RK, May HT, Anderson JL, Muhlestein JB.

Am Heart J. 2009 Nov;158(5):777-83. doi: 10.1016/j.ahj.2009.09.002.

PMID:
19853697
14.

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.

Am J Cardiol. 2008 Sep 15;102(6):733-7. doi: 10.1016/j.amjcard.2008.04.048. Epub 2008 Jul 9.

PMID:
18773998
15.

Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population.

McDonagh TA, Cunningham AD, Morrison CE, McMurray JJ, Ford I, Morton JJ, Dargie HJ.

Heart. 2001 Jul;86(1):21-6.

16.

Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study.

Law YM, Hoyer AW, Reller MD, Silberbach M.

J Am Coll Cardiol. 2009 Oct 6;54(15):1467-75. doi: 10.1016/j.jacc.2009.06.020.

17.

Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.

Ang DS, Kong CF, Kao MP, Struthers AD.

Am Heart J. 2009 Jul;158(1):133-40. doi: 10.1016/j.ahj.2009.04.024.

PMID:
19540403
18.
19.

B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome.

Detaint D, Messika-Zeitoun D, Avierinos JF, Scott C, Chen H, Burnett JC Jr, Enriquez-Sarano M.

Circulation. 2005 May 10;111(18):2391-7.

20.

Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure.

Tang WH, Girod JP, Lee MJ, Starling RC, Young JB, Van Lente F, Francis GS.

Circulation. 2003 Dec 16;108(24):2964-6. Epub 2003 Dec 8.

Supplemental Content

Support Center